Serving Gainesville,

Lake City, and Ocala, FL

Gainesville – 352-371-2800

 

 Lake City – 386-754-0999

 

 Ocala – 352-867-0045

Vitreo Retinal Associates logo vitreo-retinal-hero-6-979x340

Robert L. Roseman, M.D., F.A.C.S.

Appointments

1987-Present - Vitreo Retinal Associates, P.A. Gainesville, Florida

1989-2011 - Assistant Clinical Professor, Dept. of Ophthalmology, College of Medicine, University of Florida

June 1986-June 1987 - Director, Residency Training Program and Instructor in Ophthalmology, Dept. of Ophthalmology, Washington University

Dr. Roseman was selected as a prestigious Heed Ophthalmic Fellow, from July 1985 - June 1986.

 

He has published many articles in ophthalmic literature.

 

He has practiced and resided in Gainesville for the past 27 years.

 

Meet Dr. Roseman and Dr. Hazariwala, who have been with Vitreo Retinal Associates, P.A. for over 25 years,

and associates Dr. Christine Kay and Dr. Brandon Parrott.

Education

Undergraduate - University of Pennsylvania, B.A., September 1973 - June 1977

Medical School - Case Western Reserve University, M.D., September 1977 - June 1981

Internship - Cleveland Clinic Foundation, July 1981 - June 1982

Residency - Barnes Hospital, Washington University, July 1982 - May 1985

Fellowships - Retina Consultants, Ltd., Barnes Hospital, Washington University, Vitreoretinal Fellowship, June 1985 - June 1986

 

Licensure

American Board of Ophthalmology Diplomate - October 11, 1986

National Board of Medical Examiners Diplomate - 1982

State of Florida - July 1987

Professional Affiliations

American Society of Retina Specialists

American Academy of Ophthalmology

American College of Surgeons

Paul Cibis Club

 

 

Kaushik M. Hazariwala, M.D., F.R.C.S.(C)

Appointments

July 1998 - Present - Vitreo Retinal Associates, P.A. Gainesville, Florida

November 1994 - June 1998 - Director, Vitreoretinal Service and Asst. Professor, Dept. of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida.

August 1992 - June 1998 - Eye Care Physicians of Michigan, Jackson, Michigan.

Dr. Hazariwala received the Duncan Jamieson Award for Best Resident in the Ophthalmology Department at the University of Toronto in June 1991.

 

He also won Attending of the Year in the Ophthalmology Department at the University of Florida in June 1996.

Education

Medical School - Medical College, Baroda, India. M.B.,B.S. December 1977

Internship - Medical College, Baroda, India. January - December 1978

Residencies - Dept. of Ophthalmology, Medical College, Baroda, India. February 1979 - January 1982

Dept. of Ophthalmology, University of Toronto, Toronto, Canada. July 1988 - June 1991

Fellowships - Ophthalmic Research Fellowship, Dept. of Ophthalmology, University of Toronto, Canada. July 1985 - June 1986

Clinical and Research Fellowship, Dept. of Ophthalmology, University of Toronto, Canada. July 1986 - June 1987

Ophthalmic Pathology Fellowship, McGill University, Montreal, Canada. July 1987 - June 1988

Vitreoretinal Fellowship, The Toronto Hospital, University of Toronto, Canada. July 1991 - June 1992

Licensure

Michigan - July 1992

Florida - May 1993

Georgia - September 1993

Professional Affiliations

American Academy of Ophthalmology

American College of Surgeons

American Society of Retina Specialists

Certifications

American Board of Ophthalmology, Diplomate, October 18, 1992. Recertified in 2002

The Royal College of Physicians & Surgeons of Canada, November 1991

FLEX, December 1991

 

010copy 039 copy 039 copy

 

 

 

   

ChristineKay

Christine Nichols Kay, M.D.

Education

Certifications

2009-2011 - University of Iowa, Iowa City, IA; Vitreoretinal Surgery Fellowship

Summer 2009 - Bascom Palmer Eye Institute, Miami, FL; Visiting Fellow under mentorship

of Dr. Harry Flynn

2006–2009 - University of South Florida, Tampa, FL; Ophthalmology Residency

2005-2006 - Roanoke Carilion Memorial Hospital, Roanoke, VA; Transitional Internship

2001–2005 - University of Florida, Gainesville, FL; Doctor of Medicine, May 2005

1998–2001 - Harvard University, Cambridge, MA; Bachelor of Arts in Neurobiology; Magna Cum Laude

Summer 1991 - Oxford University, Oxford, England; Study Abroad program in English Literature

1997–1998 - Duke University, Durham, NC; Bachelor of Arts Candidate

2003 USMLE, Part I

2004 USMLE, Part II Clinical Knowledge

2005 USMLE Part II Clinical Skills and USMLE Part III

2010 American Board of Ophthalmology Written exam – Passed

2010 American Board of Ophthalmology Oral exam – Passed

Licenses

State                    Issued              Expires

Florida                 9/8/2007            1/31/2018

Iowa                    2/20/2009          8/01/2011

Professional Positions

State      Number         Type             Issued              Expires

Iowa       38258          Permanent     2/20/2009          8/01/2011

Florida   ME99947     Permanent     9/08/2007          1/31/2016

9/14-present                     Vitreo Retinal Associates; Gainesville, Florida

8/11-8/14                          Assistant Professor in Department of Ophthalmology,

                                                Vitreoretinal Surgery, University of Florida.

                                                 Director Vitreoretinal surgical service

                                                 Vitreoretinal fellowship director,

                                                 Director electrophysiology service

                                                 Director, Vitreoretinal service

9/13-present                     Independent Medical Safety Monitor (IMSM) for the New

                                        Enrollment Post-Approval Study of the Argus® II Retinal

                                        Prosthesis System

7/07–6/09                          Fee Basis Ophthalmologist

                                        James A. Haley Veterans Administration; Tampa, FL

7/03-8/03                           Summer Intern, Public Speaker for Cardiovascular Health

                                        Northeast Florida AHEC; Jacksonville, FL

5/00-8/00                           Research Intern Mass General Hospital; Cambridge, MA

1999-2001                         Multi-Disciplinary Institute for Neuropsychological

                                         Development Intern; Cambridge, MA

1999-2001                         Organic Chemistry and Physics Tutor

                                         Harvard Bureau of Study Council; Cambridge, MA

1998                                   Howard Hughes Research Fellow

                                         Duke University; Durham, NC

1997                                   Ophthalmic technician

                                         Brandon Cataract Center and Eye Clinic; Brandon, FL

HONORS AND AWARDS

2017                                  Inducted into Retina Society

2012                                  Honor Award, American Society of Retina Specialists

2008-2009                         Chief Resident, USF Ophthalmology residency

2009                                  USF Health Science Research Day: Outstanding Research                                    

2008                                  2nd Place at Florida Society of Ophthalmology Resident Research                            

2007                                  Arnold P. Gold Foundation Humanism and Excellence in

                                        Teaching Award – Carilion Roanoke Memorial Hospital

2002                                  Alpha Omega Alpha Research Award

2001                                  Harvard Hoopes Prize/Scholarship for ExcellentThesis

2000                                  Harvard College Scholarship (merit based)

2000                                  Harvard College Research Program Grant for neuroscience research

1998                                  Phi Eta Sigma Honor Society, Duke University

1998                                  Dean’s List with Distinction, Duke University

1998                                  Howard Hughes Research Grant for undergraduate research

1997                                  Valedictorian; Bloomingdale High School, Brandon, FL

Editorial Roles:

Ophthalmic Surgery Lasers and Imaging: Retina.

RETINA.

PLoS One

Human Mutation

GRANTS/RESEARCH EXPERIENCE

2016-presentPhase 1/2 Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia

Sponsored by AGTC

Role: Principal Investigator

ClinicalTrials.gov identifier: NCT02599922

 

2016-presentPhase 1/2 Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia

Sponsored by AGTC

Role: Principal Investigator

ClinicalTrials.gov identifier:

 

2015-presentPhase 2 Tolerability and Effects of ALK-001 on Stargardt Disease. Sponsored by Alkeus. (September 2015 – present)

Role: Principal Investigator.

ClinicalTrials.gov identifier: NCT02402660

 

2013-2016Clinical and genetic characterization of individuals with achromatopsia. Sponsored by NEI and AGTC.  

Role: Principal Investigator.

ClinicalTrials.gov identifier: NCT01846052

 

2011-presentFoundation Fighting Blindness, Career Development Award

(August 1, 2011 – July 31, 2016).

Role: Principal Investigator.

 

Total five year award amount: $375,000. Co-sponsors: Edwin Stone, M.D. Ph.D. and William Hauswirth, Ph.D. “Development and optimization of a viral gene delivery system for the treatment of CNGB3-associated Achromatopsia.”

University of Florida/Vitreoretinal Associates

 

2013-2014NIH sponsored study: Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes.

9/1/11 – 6/30/16   ($914,139)

(C-PI of Clinical Trial component of study.)

Principal Investigators: Dr. Grant and Dr. Raizada

University of Florida.

 

2013-2014A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan-Uveitis.(Eyeguard A Study) Sponsor: XOMA.

(4/11/2013-4/11/2017) ($61,092) 0.12 calendar months

(Role: Principal Investigator.) University of Florida.

 

2011-2014Toxicology studies for LHON AAV therapy. (Board-certified

ophthalmologist performing safety fundus exams on treated rats post-AAV therapy.)

University of Florida.

 

2009-2011 Optical coherence tomography in Best disease: using imaging

modalities to understand disease pathogenesis.

Faculty Sponsor: Edwin Stone, M.D., Ph.D.

University of Iowa.

 

2009-2011VEGF Trap-Eye: Investigation of Efficacy and Safety in Wet AMD (VIEW 1).

(Sub-investigator).

University of Iowa.

 

2009-2011Comparison of AMD Treatments Trials (CATT).  

(Sub-investigator.)

University of Iowa.

 

2007-2009Digital Interference Holography in Ophthalmology

Faculty Sponsor: Myung Kim, Ph.D. and David Richards, M.D.

University of South Florida, Department of Physics

 

2004-2005The effect of silicone oil on intraocular pressure

Faculty Sponsor: R. Ratnakaram, M.D.

University of Florida, Department of Ophthalmology

 

1999-2001  “The expression of alpha-Synuclein in Dementia with Lewy

Bodies”

Faculty Sponsor: Anne Young, M.D., Ph.D., Harvard College

Harvard undergraduate neurobiology honors tract thesis

Mass General Hospital; Boston, MA

 

1997-1998 Neurobiology research: the effect of neurotrophic factors in

ferret visual cortex

Faculty Sponsor: Donald Lo, Ph.D., Duke University

Duke University Bryan Research Center; Durham, NC

 

VISITING FELLOWSHIPS IN INHERITED RETINAL DISEASE

1) Byron Lam, Bascom Palmer Eye Institute; Miami, Florida (May 2012)

2) Gerry Fishman, Lighthouse for the Blind; Chicago, Illinois (September 2012)

3) Dick Weleber, Casey Eye Institute; Portland, Oregon (May 2013)

4) Isabelle Audo, Paris Eye Institute, Paris France (October 2013)

PUBLICATIONS (peer-reviewed)

[In print or forthcoming]

Langlo, C.S., Patterson, E.J., Higgins, B.P., Summerfelt, P., Razeen, M.M., Erker, L.R., Parker, M., Collison, F.T., Fishman, G.A., Kay, C.N., Zhang, J., Weleber, R.G., Yang, P., Wilson, D.J., Pennesi, M.E., Lam, B.L., Chiang, J., Chulay, J.D., Dubra, A., Hauswirth, W.W., Carroll, J., ACHM-001 Study Group. Residual foveal cone structure in CNGB3-associated achromatopsia. Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):3984-95. doi: 10.1167/iovs.16-19313.

 

Sun LW, Johnson RD, Langlo CS, Cooper RF, Razeen MM, Russillo MC, Dubra A, Connor TB Jr, Han DP, Pennesi ME, Kay CN, Weinberg DV, Stepien KE, Carroll J. Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome. Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2428-42. doi: 10.1167/iovs.15-18246.

 

Dedania VS, Ghodasra DH, Kay CN, Roseman R, Johnson MW. "Ciliochoroidal Effusion and Acute Macular Neuroretinopathy Associated with Cervical Traction Therapy.” Accepted to Retina Cases and Brief Reports.

 

Choi C, Zhang L, Abramoff MD, Sonka M, Shifera A, Kay CN. Evaluating Efficacy of Aflibercept in Refractory Exudative Age-Related Macular Degeneration with OCT segmentation volumetric analysis. Ophthalmic Surgery Lasers and Imaging. 2016 Mar 1;47(3):245-51

 

Shifera AS, Kay CN. Early-onset X-linked retinitis pigmentosa in a heterozygous female harboring an intronic donor splice site mutation in the retinitis pigmentosa GTPase regulator gene. Ophthalmic Genetics. 2015;36(3):251-6. doi: 10.3109/13816810.2013.879597.

 

Chen JJ, Sohn EH, Mahajan VM, Kay CN, Boldt HC, Folk JC, Russell SR. “Response of Foveal Cystoid Changes from Idiopathic Juxtafoveal Telangiectasia to Carbonic Anhydrase Inhibitors.” Retina. 2014 Jul;34(7):1400-6.

 

Bhullar SS, Gray MJ, Kay CN. “Role for rapid surgical intervention in uveal effusion syndrome with associated optic neuropathy.” Ophthalmic Surg Lasers Imaging Retina. 2014 Apr 4;45(3):e11-3. doi: 10.3928/23258160-20140331-04.

 

Cohen J, Bhullar S, Kasuga D, Boye S, Elhalis H, Kay CN. “Retinal pigment epithelial detachment in ABCA4-associated Stargardt disease.” Ophthalmic Surgery Lasers and Imaging. 2013 Jul 1;44(4):401-4.

 

Kay CN, Ryals RC, Aslanidi GV, Min SH, Ruan Q, Dyka FM, Kasuga D, Ayala AE, Van Vliet K, Agbandje-McKenna M, Hauswirth WW, Boye SL, Boye SE. “Targeting Photoreceptors Via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors.” PLoS One 2013 Apr 26;8(4):e62097.

 

Bhalla S, Joshi D, Bhullar S, Kasuga D, Park Y, Kay CN. Long term follow-up data for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.” British Journal Ophthalmology 2013 Jul;97(7):895-9.

 

Hollsten JE, McClintock M, Samy H, Peden M, Kay CN. “Fulminant chorioretinitis and papillitis secondary to coxsackievirus B virus presenting as acute posterior multifocal placoid pigment epitheliopathy with positive response to IVIG.” Accepted to Retina Cases and Brief Reports.

 

McClintock M, Peden MC, Kay CN. “Spectral domain optical coherence tomography findings in siblings with CNGB3-associated achromatopsia.” Adv. Exp. Med. Biol 2014;801:551-7. doi: 10.1007/978-1-4614-3209-8_70.

 

Boye SL, Peshenko IV, Huang WC, Min SH, McDoom I, Kay CN, Liu X, Dyka FM, Foster TC, Umino Y, Karan S, Jacobson SG ,Baehr W, Dizhoor A, Hauswirth WW and Boye SE. “AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis." Hum Mol Gene Therapy 2013 Feb;24(2):189-202.

 

Russell SR, Sohn EH, Boldt HC, Folk JC, Tarantola RM, Kay CN, Mahajan VM. “Elimination of infusion bubbles and uncontrolled reflux in the Alcon constellation vitrectomy vision system.” Retina 2013 Apr;33(4):803-6.

 

Kay CN, Quiram P, Mahajan VM. “23-Gauge Pediatric Vitrectomy using Limbus-based Trocar-Cannulas. Retina. 2012 May;32(5):1023-7.

 

Kay CN, Abramoff MD,  Mullins RF, Kinnick TR, Lee K, Chung MM, Sohn EH, Stone EM. “Three dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with Best vitelliform macular dystrophy.” Arch Ophthalmol. 2012 Mar;130(3):357-64.

 

Kay CN, Pavan PR, Small LB, Zhang T, Zamba GKD, Cohen SM. “Familial Trends in a Population with Macular Holes.”  Retina. 2012 Apr;32(4):754-9.

 

Kay CN, Tarantola RM, Gehrs KM, Folk JC, Mahajan VB, Boldt HC, Syed N, Russell SR. “Uveitis Following Intravitreal Bevacizumab Injection: A Non-Infectious Cluster.” Ophthalmic Surgery Lasers and Imaging. 2011 Jul-Aug;42(4):292-6.

 

Kay CN, Elkins KA, Folk JC. “Resolution of refractory macular edema due to branch retinal vein occlusion after Ozurdex implantation.”  Accepted to Retina Cases and Brief Reports.

 

Kinnick TR, Mullins RF, Dev S, Leys M, Mackey D, Kay CN, Lam BL, Fishman GA, Traboulsi E, Stone EM.  “Autosomal Recessive Vitelliform Macular Dystrophy in a Large Cohort of Vitelliform Macular Disease Patients.” Retina. 2011 Mar;31(3):581-95.

 

Tarantola RM, Elkins KA, Kay CN, Folk JC.  “Photoreceptor Recovery Following Laser Photocoagulation and Albendazole in Diffuse Unilateral Subacute Neuroretinitis.”  Arch Ophthalmol. 2011 May;129(5):669-71.

 

Kay CN, Saunders T, Pavan PR. “Ocular Injuries Sustained in Paintball Trauma.” Graefe’s Archive for Clinical and Experimental Ophthalmology 2010 Mar;248(3):331-2.  

 

Potcoava M, Kay CN, Kim MK, Richards DW. “In vitro imaging of ophthalmic tissue by digital interference holography.” Journal of Modern Optics 2009.

 

Kay CN, Pavan PR, Burrows A, Martino AZ. "Neurosensory Retinal Detachment of the Macula in Retinal Phototoxicity Documented by Optical Coherence Tomography." Accepted to Retinal Cases and Brief Reports.

 

Kay CN, Gendy MG, Lujan BJ, Punjabi OS, Gregori G, Flynn HW. “Composite Spectral Domain Optical Coherence Tomography Images of Diabetic Tractional Retinal Detachment.” Ophthalmic Surgery Lasers and Imaging 2008; 39:S99-S103.

 

(Kay) Nichols C, Pincus DW, Bhatti MT. "Optociliary Shunt Vessels."  Neurology 64: 1443. April 2005.

 

[Submitted & In Preparation]

Min SH, Boye SL, Ryals RC, Ruan Q, Sun J, Dyka F, Hauswirth WW, Boye SE, Kay CN. Long-term restoration of visual function in the CNGB3/NRL double knockout mouse, a cone-dominant model of CNGB3-achromatopsia. In preparation.

 

Hu JK, Blanford AD, Jan JT, Rocke BA, Kay CN. Angiographic reperfusion of choroidal occlusion and associated recovery in visual acuity and field after rapid anticoagulation. Submitted to DJO.

Choi C, Zhang L, Abramoff MD, Sonka M, Shifera A, Kay CN. Evaluating Efficacy of Aflibercept in Refractory Exudative Age-Related Macular Degeneration with OCT segmentation volumetric analysis. Submitted to AJO..

Kasuga D, Ross A, Exume M, Kay C. Relative Efficacy of Various Treatment Modalities for  Cystoid Macular Edema in Retinitis Pigmentosa. Submitted to Retina.

 

PRESENTATIONS AT NATIONAL MEETINGS

[Oral Presentations]

 

Kay CN, Hu J. Angiographic reperfusion of choroidal occlusion and associated recovery in visual acuity and

field after rapid anticoagulation. IVFA conference at ASRS, San Diego CA 2014.

 

Kay CN and Bhalla S. Long-term efficacy and safety of treatment of retinitis pigmentosa with

valproic acid. ASRS 2013.

 

Kay CN and Bhalla S. Long-term efficacy and safety of treatment of retinitis pigmentosa with

valproic acid. ARVO 2013.

 

Kay CN, Hollsten J, McClintock, Peden M, Samy H. “A case of fulminant bilateral chorioretinitis

and papillitis.” American Society of Retina Specialists: Las Vegas, Nevada; 2012.

 

Kay CN, Joshi D, Gray M. Uveal effusion syndrome with associated anterior ischemic optic

neuropathy with dramatic improvement after scleral windows procedure.” American Society of

Retina Specialists: Las Vegas, Nevada; 2012.

 

Russell SR, Mahajan VB, Boldt HC, Folk JC, Sohn EH, Kay CN, Tarantola RM. “Constellation 2.0:

Eliminating Infusion Bubbles and Uncontrolled Reflux.” Retina Society Meeting: Rome, Italy; 2011

 

Kay CN, Mullins RF, Kinnick T, Stone EM.  “Morphology of the Vitelliform Lesion in Best Disease.” American Society of Retina Specialists: Vancouver, Canada; August 2010.

 

Kay CN, Tarantola RM, Folk JC.  Fluorescein case conference: “DUSN.” American Society of Retina Specialists: Vancouver, Canada; August 2010.

 

Folk JC, Stone EM, Kay CN, et al. “Molecular Genetics of AMD and its response to treatment.”  Paper presentation at 28th annual meeting of American Society of Retina Specialists, Vancouver, Canada; August 2010.

 

Potcoava M, Kay CN, Kim MK, Richards DW. “Digital Interference Holography in Ophthalmology.” ARVO 2008.

 

Kay CN and Pavan PR. “Ocular injuries sustained in paintball trauma.” Free Paper Session.  Fourth International Ophthalmologic School organized by Croatian Society for Cataract and Refractive Surgery. Croatia; May 2008.

 

Kay CN, Potcoava M, Kim MK, Richards DW.  “Digital Holography Imaging of Human Macula.”  Paper Presentation. Florida Society of Ophthalmology Resident Symposium. Palm Beach, FL; June 2008.  

 

Kay CN, Cohen SM, Pavan PR, Small LB. “A family history study of macular holes.” Gass Society Meeting. Paper presentation. Honolulu, Hawaii; October 2008.

 

Kay CN, Pavan PR, Kelty PJ. “Ocular injuries sustained in paintball trauma.”  Paper presentation. American Society of Retina Specialists: Maui, Hawaii; October 2008.

 

Kay CN, Pavan PR. “Case of Lupus causing peripheral neovascularization and tractional retinal detachments.”  Grand Rounds presentation, Women in Retina Symposium, American Society of Retina Specialists: Maui, Hawaii; October 2008.

 

Kay CN, Potcoava M, Kim MK, Richards DW. “Imaging of Human Optic Nerve with Digital Interference Holography.”  Paper Presentation. Asia ARVO: Hyderabad, India: January 2009.  

 

Potcoava MC, Kim MK, Kay CN. “Wavelength scanning digital interference holography for high-resolution ophthalmic imaging.” SPIE 2009 BiOS Biomedical Optics Symposium 2009. Ophthalmic Technologies XIX, section 3-Ophthalmic Imaging Technology II . San Jose, CA. January 2009.

 

 

[Courses at National Meetings]

 

Kay CN (course organizing faculty) with co-faculty: Duncan J, Lam B, Pennesi M, Michaelides M, Sohn E, Audo I. Instructional course at AAO 2014. “A genetic approach to inherited retinal dystrophies: clinical classification of common retinal dystrophies, genotyping, and gene therapy.”

 

Kay CN and Bakall B.  Instructional course: A genetic approach to inherited retinal dystrophies: updates on clinical classification of common retinal dystrophies, genotyping, and gene therapy.  ASRS 2014 San Diego.

 

Kay CN and Sohn E.  Instructional course: A genetic approach to inherited retinal dystrophies: updates on clinical classification of common retinal dystrophies, genotyping, and gene therapy.  ASRS 2013, Toronto.

 

[Poster Presentations]

Sarfare S, Min SK, Ruan Q, Boye SL, Boye SE, Hauswirth WW , Kay CN. The expression of CNGB3 provides a long-term rescue in the cone-only CNGB3 x NRL double knock-out (DKO) mouse. ISER 2014.

 

Choi C, Zhang L, Abramoff MD, Sonka M, Shifera A, Kay CN. Evaluating Efficacy of Aflibercept in Refractory Exudative Age-Related Macular Degeneration with OCT segmentation volumetric analysis.

San Diego, CA: ASRS 2014.

 

Choi C, Zhang L, Abramoff MD, Sonka M, Shifera A, Kay CN.  Efficacy of Aflibercept in Refractory Wet Age-Related Macular Degeneration. ARVO 2014.

Min SK, Ruan Q, Boye SL, Boye SE, Hauswirth WW , Kay CN. The expression of CNGB3 provides a long-term rescue in the cone-only CNGB3 x NRL double knock-out (DKO) mouse. ARVO 2014.

Radhakrishnan K, Parsons-Wingerter P, Chalam KV, Mames R, Kay C, Grant MB. VESGEN Analysis of Fractal-Based Branching in Arterial and Venous Trees for Investigating Diabetic Retinopathy with Spectralis® Angiographic Imaging. ARVO 2014.

 

Hauswirth W, Min SH, Boye SL, Kasuga DT, Ruan Q, Sun J,  Phan MT,  Boye SE, Kay CN. Natural History of the CNGB3/NRL Double Knock-Out Mouse. ARVO 2013.

In vivo quantification of photoreceptor transduction efficiency using novel modified AAV capsids. Ryals R, Kay CN,  Boye SL, Min SH, Ayala S, Hauswirth WW, Boye SE. ARVO 2013.

 

Kay CN, Boye S, Ryals R, Sun J, Neeley A, Hauswirth B, Boye S. “Enhanced Retinal Transduction Via The Vitreous With AAV8 Capsid Mutants.”ASRS 2012.

 

Kay CN, Boye S, Ryals R, Sun J, Neeley A, Hauswirth B, Boye S. “Enhanced Retinal Transduction Via The Vitreous With AAV8 Capsid Mutants.”ARVO 2012.

 

Kay CN, Tarantola RM, Mullins RF. “Histopathologic Correlation of Retinal Layers on Spectral Domain Optical Coherence Tomography in Post-mortem Human Eyes.” ASRS: Boston, MA; 2011.

 

Kay CN, Stone EM, Abramoff MD. “Increased thickness of photoreceptor outer segments and retinal pigment epithelium in Best vitelliform macular dystrophy.” ARVO 2011.

 

Kay CN, Elkins KA, Mahajan VB, Gehrs KM.  “Reversal of Visual Field Defects on Goldmann Perimetry after Fluocinolone Acetonide Implantation for Chronic Uveitis.”  American Society of Retina Specialists: Vancouver, Canada; August 2010.

 

Kay CN, Tarantola RM, Gehrs KM, Russell SR.  “Non-infectious uveitis following intravitreal bevicizumab.”  Poster presentation.  ARVO 2010.  

 

Kay CN, Cohen SM, Pavan PR, Small L. "Prevalence of familial trends in a population with macular holes." Poster presentation.  Retina Congress 2009 NY. And t

 

Kay CN, Potcoava M, Kim MK, Richards DW, Pavan PR.  “Digital Holography Imaging of Human Macula.”  Poster Presentation. American Society of Retina Specialists: Maui, Hawaii; October 2008.

 

Kay CN,  Zaccaria AL, Burrows A, Pavan PR. “The OCT findings in retinal phototoxicity.” Poster presentation.  American Society of Retina Specialists: Palm Springs, California 2007.

 

Nichols C, Seeburg D, Vaishnav H, WC Lara, Feistmann J, Kaushal S, Ratnakaram R.  “Does the use of silicone oil in retina surgery induce glaucoma?” Poster Presentation.  ARVO 2005.

 

Nichols CM, Miller DW, Johnson JM, Young AB. “Decreased Alpha-Synuclein mRNA Expression in Dementia with Lewy Bodies.” Massachusetts Alzheimer's Disease Research Center Poster Session, January 2002.

INVITED LECTURES:

"Achromatopsia: Overview and Gene Therapy Updates" Achromacorp Convention, Wisconsin 2017

 

“The Doctor is in” panel, Foundation Fighting Blindness; Baltimore, MD.  VISIONS 2016

 

Foundation Fighting blindness chapter meeting: Gainesville, FL: “Genetic testing for retinal dystrophies.” September 2014.

 

“The Doctor is in” panel, Foundation Fighting Blindness; Denver, Colorado.  VISIONS 2014.

 

“Eylea and the anti-VEGF era” – Department of Pharmacology, University of Florida, December 6, 2014.

 

Clinical Overview of Achromatopsia:  Achromatopsia National Convention; University of Florida, June 2014.

 

“Achromatopsia: clinical overview, gene therapy overview/proof of concept in mice and large animals, and clinical trial update.  Institut de Vision; Paris, France. October 2013.

 

“A genetic approach to inherited retinal dystrophies: updates on clinical classification of common retinal dystrophies, genotyping, and gene therapy.” Croatian Ccataract and Refractive Society.  Zagreb, Croatia. October 2013.

 

“Overview: Rare retinal dystrophies” – Foundation Fighting Blindness Annual Meeting, VISIONS 2013, Baltimore, MD, June 2012.

 

“Genetics of Inherited Retinal Disease.”  Invited speaker by Dr. Scott Friedman for Retinal Consultants of Florida sponsored dinner meeting; Lakeland, Florida; April 2013.

 

Moderator for Vitreoretinal surgical fellow case conference at Vit-Buckle Society; April 2013.

 

“Diabetic retinopathy for the internist” – January 18, 2012, University of Florida; internal medicine grand rounds

 

“Translational approach to inherited retinal disease.” Florida Society of Ophthalmology, Orlando, FL June 2012

 

“Overview: Stargardt disease, Cone-rod dystrophy, Best vitelliform macular dystrophy” – Foundation Fighting Blindness Annual Meeting, VISIONS 2012, Minneapolis, Minnesota, June 2012

 

“Clinical characterization of inherited retinal disease.” Lions Club, Gainesville, FL; August 2012

 

“Translational approach to inherited retinal disease.” University of Florida, Pre-Meeting to Inherited Retinal disease Symposium: “Gene Therapy 101”; Gainesville, FL October 2012

 

“The Doctor is in” panel, Foundation Fighting Blindness, Invited by Jacksonville chapter of FFB, October 2012

 

“Diabetic retinopathy clinical update” – UF Diabetes Center of Excellence “A celebration of research and patient care”, November 16, 2012.

 

“A genetic approach to inherited retinal disease,” Retina Pearls at University of Florida, a CME event, December 14, 2012

 

“Diabetic retinopathy” – January 2013, University of Florida; endocrinology grand rounds.

PRESENTATIONS AT LOCAL MEETINGS

Kay CN, Shifera AS.  "Familial exudative vitreoretinoathy."  Sarasota Retina Conference;

Sarasota, FL  March 2013.

 

Invited panel discussant/participant: “Clinical management of diabetic retinopathy”; panel members included myself, Susan Bressler, Neil Bressler, Rick Spaide. Sarasota Retina Conference; Sarasota, FL March 2013.

 

Ryals R, Kay C, Boye S, Min SK, Sun J, Dyka F, Ayala A, Hauswirth W, Boye S. “Targeting photoreceptors via intravitreal delivery of novel, capsid-mutated AAV vectors.” Poster. University of Florida College of Medicine Celebration of Research Day; March 11, 2013.

 

“Achromatopsia”.  Poster, Rare Disease Day, University of Florida; Gain

 

 

MEETINGS ORGANIZED:

Organized retina pearls of Practice and served as moderator at this meeting at University of

Florida, December 9, 2012. Guest speakers: Steve Russell (University of Iowa), Timothy Murray (Bascom Palmer)

 

Organized Inherited Retinal disease symposium which will be held at the University of Florida in October 2012. (Guest speakers: Bill Hauswirth, Gerry Fishman, Sam Jacobson, Jane Sowden, Jacque Duncan, Mina Chung.

TEACHING EXPERIENCE

11/12 IDP dissertation committee member for graduate student Renee Ryals, PHD candidate at

University of Florida.

8/12- Rotating medical students mentored in August 2012 in both clinic and lab: Peter Tang (MUSC medical student) and Josh Cohen, Univ of Florida

8/11- Retina fellowship co-director: (Retina fellows taught: Deval Joshi, M.D.) (2012-2013; Shaminder Bhullar 2012-)

8/11- Mentor to Sheena Bhullar for Medical Student Research Program for

research for medical students.

8/11- MEL4012: serve as faculty mentor to students (Osmanny Gomez,

Aureen Arellano, Hannah Hong, Brian Rossmiller) shadowing me for clinical/surgical experience

MEL7933: faculty instructor for ophthalmology elective at University of Florida

BCC1760: faculty instructor for surgery clerkship

8/11- Faculty Mentor to Renee Ryals for Clinical and Translational Science

Institute Program (2012-2014)

8/11-Assistant professor at University of Florida – teach residents and

fellows in clinic and operating room, give lectures on retina

and fluorescein angiography

7/09-6/10 Weekly fluorescein conferences – present to residents/faculty

7/09-6/11 Retinal Anatomy - Medical Student Lecture Series

7/09-6/11 Clinical instruction of residents (clinic, surgery, on-call)

PROFESSIONAL LEADERSHIP ACTIVITIES

2012-presentSteering committee member and Regional direct of RAFA (Retinal advocacy and

federal affairs, committee of American Society of Retinal Specialists)

2010-presentMember of WINR, Women in Retina, ASRS

2012-presentWomen in Ophthalmology at University of Florida founder

2011-presentVitreoretinal Fellowship Director

Director Electrophysiology Service

Director Clinical Research, Vitreoretinal Division

2008-2009Chief Resident, University of South Florida Ophthalmology

2008American Retina Foundation delegate for AAO Advocacy  

Ambassador Program Mid-Year Forum; Washington, D.C.

2008-presentReviewer for Ophthalmic Surgery, Lasers and Imaging

2012-presentReviewer for Canadian Journal of Ophthalmology

2002-2003Vice President, University of Florida AMA Chapter

2002-2003Atkins Economic Society Chair

1994-present Equestrian: own/train/ride two Arabian horses

2002-presentTriathlon competitor (Half-Iron Man 2002, marathon 2002)

2006-presentRecreational kayak races, Florida

2001-2005Equestrian recreational cross-country riding and fox-hunting

2004-2005Yearbook Editor, University of Florida College of Medicine

2000Hiking trip leader for Freshman Outdoor Program, Harvard

1999-2001Intramural Crew, Harvard University

1997-1998Equestrian Team, Duke University

EXTRACURRICULAR ACTIVITIES

PROFESSIONAL SOCIETIES

2009-presentAmerican Society of Retina Specialists

2009-presentIowa Eye Association

2006-presentAmerican Academy of Ophthalmology

2006-presentARVO

2006-presentFlorida Society of Ophthalmology

2001-presentAmerican Medical Association

2001-2005American Medical Student Association

2001-2005Florida Medical Association

parrott

_______________________

 

Brandon Parrott. M.D., Ph.D.

_________________________

EMPLOYMENT__________________________________________________________________

 

SurgeonVitreoRetinal Associates

Starting June 2017

Gainesville, FL

 

SurgeonCenter for Sight

May 2012 – present

Sarasota, Florida

 

SurgeonTennessee Retina, P.C.,

August 2010 – March 2012

Nashville, Tennessee

 

Instructor      Chief Resident

July 7th, 2009 – July 7th, 2010

Bascom Palmer Eye Institute (BPEI) / University of Miami

Miami, Florida

 

Fellowship Vitreoretinal Fellow

July 7th, 2008 – July 7th, 2009

Bascom Palmer Eye Institute (BPEI) / University of Miami

Miami, Florida

 

Residency Bascom Palmer Eye Institute / Jackson Memorial Health System,

July 1st, 2005 – June 30th, 2008

Miami, Florida

Ophthalmology Residency

 

InternshipChristus St. Joseph Hospital, June 18th, 2004 - June 20th, 2005

Houston, Texas

Transitional Year Internship

 

EDUCATION___________________________________________________________________                                                                                                                                  

 

M.D.Baylor College of Medicine (BCM), May 25th, 2004

NIH - Medical Scientist Training Program

Houston, Texas

With Honor

Alpha Omega Alpha Honor Society

Honors for Academic Performance in the Basic Sciences

 

Post-Baylor College of Medicine, July 2002 - April 2003

Sophomore Department of Pathology

FellowshipHouston, Texas

Ocular pathology with Patricia Chevez-Barrios, M.D. and Ramon L. Font, M.D.

 

Ph.D.Baylor College of Medicine, July 5th, 2002

Department of Immunology

Center for Cell and Gene Therapy

NIH - Medical Scientist Training Program

Houston, Texas

Advisor:  Michael A. Barry, Ph.D.

Thesis: “Development of metabolically biotinylated adenoviral vectors for generating targeted gene therapy”

 

B.S.University of Tennessee (UTK), August 1990 – May 12th, 1995

Knoxville, Tennessee

Summa cum laude

Whittle Scholarship for Leadership and Academic Excellence  

GPA 3.99

Majors: Biomedical Engineering and Biochemistry

 

Victoria University of Technology, January 1994 - April 1994

Melbourne, Australia

Whittle Scholar Study Abroad Program

 

 

HONORS and AWARDS

 

2016 Top Doctor – Castle Connolly

2011Top Ophthalmologist – International Association of Healthcare Professionals

2010-15Compassionate Doctor Award – Patients’ Choice Organization

2005In-service Exam Award – Christus St. Joseph Hospital

2004 Most Outstanding Performance in the Clinical Sciences – BCM MD/PhD program

2004  Alpha Omega Alpha Honor Society - BCM

2002Best Oral Abstract Presentation – Center for Cell and Gene Therapy Symposium – BCM

2001 First Place Poster Presentation – Center for Cell and Gene Therapy Symposium - BCM

2001First Place Outstanding Platform Presentation – Baylor College of Medicine MD/PhD Symposium - BCM

2001First Place Speaker Award – Department of Immunology Student Symposium - BCM

1997Honors for Academic Performance in the Basic Sciences - BCM

1995-2004Presidential Scholarship Award - BCM

1995-2004NIH-Medical Scientist Training Program Fellowship - BCM

1995Chancellor's Citation for Extraordinary Academic Achievement – UTK

1995L. Raymond Shobe Award for Leadership and Academic Excellence in Engineering – UTK

1996Engineering Science and Mechanics Outstanding Student Scholarship - UTK

1994Most active member award - Alpha Epsilon Delta (Pre-medical Honor Society) - UTK

1994Inducted into Tau Beta Pi (Engineering Honor Society)

1990-95      Whittle Scholarship for Leadership and Academic Achievement  - UTK

1990Tennessee Academic Scholar

1990National Merit Finalist

1990 First Place in State of Tennessee in TMTA Advanced Calculus Competition

 

 

PUBLICATIONS

 

Kuriyan, AE, Albini TT, Townsend JH, Rodriguez M, Pandya HK, Leonard RE, Parrott MB, Rosenfeld

Pj, Flynn HW, Goldberg JL: Vision loss after intravitreal injection of autologous “stem cells” for AMD. New England Journal of Medicine 2017: 376:11:1047-1053.

 

Wykoff CC, Parrott MB, Flynn HW Jr, Shi W, Miller D, Alfonso EC:  Nosocomial acute-onset

postoperative endophthalmitis at a university teaching hospital (2002-2009).  American Journal of Ophthalmology 2010: Sep 150(3):392-398.

 

 

 

Cavalcante LL, Cavalcante ML, Murray TG, Vigoda MM, Piña Y, Decatur CL, Davis RP, Olmos LC,

Schefler AC, Parrott MB, Alliman KJ, Flynn HW, Moshfeghi AA:  Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.  Clinical Ophthalmology 2010:  May 25(4):519-524.  

 

Parrott MB:  Evolution of the treatment of neovascular AMD in the age of anti-VEGF agents.  TheOphthalmology Report 2010:  3(3):16-20.

 

Parrott, MB: The evolution of current and future treatments for neovascular AMD.  The

Ophthalmology Report 2009: 2(2):16-20.

 

Campos SK, Parrott MB, Barry MA:  Metabolically biotinylated pIX-modified adenovirus for single-

step affinity purification of viral vectors.  Molecular Therapy 2004: 9(6):942-54.

 

Blum JS, Parrott MB, Mikos AG and Barry MA:  Early osteoblastic differentiation induced by

dexamethasone enhances adenoviral gene delivery to marrow stromal cells.  Journal of Orthopaedic Research 2003: 22(2):411-416.

 

Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, and Barry MA:  Metabolically biotinylated

adenovirus for cell-targeting, ligand screening, and vector purification.  Molecular Therapy 2003: 8(4):688-700.

 

Takahashi S, Mok H, Parrott MB, Marini FC, Andreeff M, Brenner MK, and Barry MA:  Selection of chronic lymphocytic leukemia targeting peptides.  Cancer Research 2003: 63(17):5213-5217.

 

Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, and Parrott MB:  Biotinylated

 gene therapy vectors. Expert Opinion in Biological Therapy 2003: 3(6):925-940.

 

Barry MA, Takahashi S, and Parrott MB: Selection of Peptides on Phage. In Vector Targeting for Therapeutic Gene Delivery.  (DT Curiel and JT Douglas Eds.) John Wiley & Sons, Inc. New York, NY 2002.

 

Parrott MB and Barry MA: Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. BBRC 2001: 281:993-1000.

 

Parrott MB and Barry MA: Metabolic biotinylation of recombinant proteins in

mammalian cells and in mice. Molecular Therapy 2000: 1(1):96-104.

 

 

CLINICAL RESEARCH PROTOCOLS_________________________________________________

 

HAWK - NCT02307682 – Efficacy and Safety of RTH258 Versus Aflibercept - The purpose of this study is to compare RTH258 ophthalmic solution for intravitreal (IVT) injection at two dosage levels to aflibercept solution for IVT injection (2 mg) in subjects with untreated active choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) in the study eye. – Alcon.

 

PROXIMA A - NCT02479386 - Epidemiologic Study of Disease Progression in Patients With

Geographic Atrophy Secondary to Age-Related Macular Degeneration - This study seeks to better characterize relationships between visual function and the progression (worsening) of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study is also intended to generate new information on the relationship between genetics and GA progression. - Hoffmann-La Roche.

 

 

 

 

CEDAR -  NCT02462928 - Safety and Efficacy Study of Abicipar Pegol in Patients With

Neovascular Age-related Macular Degeneration – This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration. – Allergan.

 

ORBIT - NCT02079883 – Ocriplasmin Research to Better Inform Treatment - Multicenter, prospective, observational, Phase 4 study assessing clinical outcomes and safety of JETREA® administered in a real-world setting for the treatment of symptomatic vitreomacular adhesion (VMA) by assessing anatomical and functional outcomes. – Thrombogenics.

 

SHORE – NCT01277302 - A Study Evaluating Dosing Regimens for Treatment With Intravitreal

Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion - This was a Phase IV multicenter, randomized, open-label study, of the efficacy and safety of intravitreal ranibizumab 0.5 mg in subjects with macular edema following Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO). – Genentech.

 

FOVEA (FOV2304) - NCT01319487 - Safety and Efficacy Study of Topical Administration

of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy - The purpose of the study is to determine whether concentrations of FOV2304 (high dose or low dose) administered in the eye are more effective than placebo in treating patients with diabetic macular edema, following 12 weeks of treatment. - Fovea Pharmaceuticals SA.

 

Novartis HMT –  NCT01542866 - A 16 Week Evaluation of the Novartis Health Management Tool

(HMT) in Age Related Macular Degeneration - This is a prospective pilot study to evaluate the usability and applicability of a self-monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in disease status. – Novartis Pharmaceuticals.

 

DODO (FVF4155s) - NCT00533520 -  Evaluation of Dosing Interval of Higher Doses of

Ranibizumab - Phase 4 study to test the safety, tolerability and effectiveness of a higher doses (1.0 mg and 2.0 mg) of ranibizumab versus the standard dose (0.5 mg), in adults with age related macular degeneration who have never been treated with ranibizumab. – Genentech.

 

VISTA - NCT01363440 - Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in

Patients With Diabetic Macular Edema - The purpose of this study is to determine the efficacy of Intravitreal Aflibercept Injection on the best corrected visual acuity (BCVA) in patients with diabetic macular edema (DME) with central involvement.- Regeneron Pharmaceuticals.

 

Foresee Home Device Study (PT US 001) - NCT01334294 – Home Vision Monitoring Using the

ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration. - The purpose of the current study is to evaluate if, in post-treatment patients, PHP parameters as measured with the ForeseeHome are in agreement with clinical decisions and retinal characteristics as measured with optical coherence tomography (OCT). - Notal Vision Ltd.

 

MAHALO – NCT01229215 - A Study of Safety, Tolerability, and Evidence of Activity of  

FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy - Phase Ib/II, multicenter, randomized, single-masked, sham-injection-controlled study of safety, tolerability, and evidence of activity of FCFD4514S intravitreal injections administered monthly or every other month in patients with geographic atrophy. – Genentech.

 

 

RESEARCH EXPERIENCE

 

1998-2002 Baylor College of Medicine - Houston, TX

Department of Immunology and the Center for Cell and Gene Therapy

Advisor: Michael A. Barry, Ph.D.

M.D./Ph.D. Candidate - investigated the targeting of retroviral and adenoviral vectors to selected cell types by modifying the viral envelopes and capsid proteins of gene therapy viral vectors

 

 

1994-1995     University of Tennessee School of Veterinary Medicine - Knoxville, TN

Department of Orthopedic Surgery

Advisor: Jack Wasserman, Ph.D.

Biomedical Engineering Honors Thesis - tested structural integrity and compared biomechanical properties of a novel PMMA trans-hock external fixation device versus a traditional KE stainless-steel fixation device

 

1992-93Oak Ridge National Laboratory - Oak Ridge, TN

Chemical Engineering Division

Consultant - completed uranium contamination resorption project and trained post-doctoral engineer in newly established protocols

 

1992Oak Ridge National Laboratory - Oak Ridge, TN

Chemical Engineering Division

Research Intern - assisted in the design and testing of a biologically based uranium absorption system for the purification of uranium contaminated water

 

1991Oak Ridge National Laboratory - Oak Ridge, TN

Energy Sciences Division

Research Intern - investigated enhancing the efficiency of heat pump technology through innovative design and use of computer models to test the efficiency of prototype heat pumps

 

 

ORAL PRESENTATIONS AND ABSTRACTS

 

Nov 2015 Oral Platform Presentation - Vision Loss Consequent to Intravitreal Stem Cell Injection

Albini TA, Kuriyan AE, Townsend JH, Rodriguez M, Pandya HK, Leonard RE, Parrott MB,  Rosenfeld PJ, Flynn HW

2015 Annual Meeting – American Academy of Ophthalmology – Las Vegas, NV

 

Nov 2008 Poster – Nosocomial Acute-onset postoperative endophthalmitis at a university teaching hospital

Wykoff CC, Flynn HW, Miller D, Parrott MB, Murray TG, Smiddy WE, Davis JL  

2008 Annual Meeting – American Academy of Ophthalmology

 

Nov 2007 Poster – Intravitreal bevacizumab use for progressive ROP and Best disease related choroidal neovascular membranes

Parrott MB, Murray, TG, and Berrocal AM

2007 Annual Meeting – American Academy of Ophthalmology  

 

June 2007 Oral Platform Presentation – Nosocomial acute-onset postoperative endophthalmitis survey: An 11-year review of incidence, causative organisms, and outcomes

Parrott MB, Wykoff CC, and Flynn HW

43rd Annual Bascom Palmer Eye Institute Resident’s Day – Miami, FL

 

May 2007 Poster – Nosocomial acute-onset postoperative endophthalmitis survey: An 11-year review of incidence, causative organisms, and outcomes

Parrott MB, Wykoff CC, Miller D, Newton J, and Flynn HW

ARVO 2007 Annual Meeting – Fort Lauderdale, FL

 

June 2003 Oral Platform Presentation – Metabolically Biotinylated Viruses for Vector Targeting and Purification

Campos SK, Parrott MB, Adams KE, and Barry MA

Sixth Annual Meeting of the American Society of Gene Therapy – Washington, DC

 

March 2003 Poster – Metabolically biotinylated gene therapy vectors for vector targeting and purification

Campos SK, Parrott MB, Adams KE, Blum JS, Mok H, Muzykantov V, and Barry MA

Cold Spring Harbor Symposium on Vector Targeting Strategies for Gene Therapy - Cold Spring Harbor, NY

 

 

March 2003Poster – Selection and application of CLL-targeting peptides using peptide-presenting phage libraries

Takahashi S, Mok H, Parrott MB, Marini FC, Andreeff M, Brenner MK, and Barry MA

Cold Spring Harbor Symposium on Vector Targeting Strategies for Gene Therapy - Cold Spring Harbor, NY

 

Jan. 2003Poster – Apoptosis, mitotic rate, and age correlations in the regression of periorbital hemangiomas

Parrott MB, Font RL, and Chevez-Barrios P

Eighty-Second Annual Texas Society of Pathologists Meeting – Houston, TX

 

June 2002Oral Platform Presentation – Metabolically biotinylated adenoviral vectors for targeted gene therapy

Parrott MB and Barry MA

Fifth Annual Meeting of the American Society of Gene Therapy – Boston, MA

 

May 2002Oral Platform Presentation - Use of in vivo biotinylated adenoviral vectors for targeted gene therapy

Parrott MB and Barry MA

Forty-Third Annual National Student Research Forum – Galveston, TX

 

Dec. 2001Poster - Selection of leukemia-targeting peptides using peptide presenting phage libraries

Takahashi S, Barry ME, Parrott MB, Brenner MK, and Barry MA

Forty-Third American Society of Hematology Annual Meeting - Orlando, FL

 

June 2001Poster - Metabolically biotinylated gene therapy vectors

Parrott MB and Barry MA

Fourth Annual Meeting of the American Society of Gene Therapy - Seattle, WA

 

March 2001Oral Platform Presentation - Metabolically biotinylated adenoviral and retroviral vectors

Parrott MB and Barry MA

Cold Spring Harbor Symposium on Vector Targeting Strategies for Gene Therapy - Cold Spring Harbor, NY

 

June 2000Poster - Metabolic biotinylation of recombinant proteins for viral gene therapy vector targeting  

Parrott MB and Barry MA

Third Annual Meeting of the American Society of Gene Therapy - Denver, CO

 

March 1999Poster - Selecting lung targeting peptides in vivo

Parrott MB and Barry MA

Cold Spring Harbor Symposium on Vector Targeting Strategies for Gene Therapy - Cold Spring Harbor, NY

 

 

TEACHING EXPERIENCE

 

2009-2010        Chief Resident, BPEI

2006-2009 Teaching Assistant for Neuro-Ophthalmology Course, BPEI

1997-2004Teaching Assistant and Graduate Lecturer, Department of Immunology, BCM

2003Conference Leader, Department of Pathology, BCM

1996-1999Conference Leader and Graduate Lecturer, Physiology, BCM

1996-2000Student Affairs Tutor, Biochemistry and Physiology, BCM

1995                  Engineering Specialty Course - Tennessee Governor's School for the Sciences, UTK

 

 

 

GRANTS and FELLOWSHIPS

 

2003-2004American Medical Association Foundation Research Seed Grant

1999-2002National Research Service Award from National Institutes of Health

1995-2004National Institutes of Health - Medical Scientist Training Program Grant

 

 

EXTRACURRICULAR and VOLUNTEER ACTIVITIES

 

2010-presentPartners for Healing

2000-2001Graduate Student Council Representative

1997Pediatrics Course Steering Committee

1995-1998    Preclinical Resource Network for Incoming Medical Students

1995-1997Medical Scientist Training Program Student Operating Committee

 

 

PROFESSIONAL ORGANIZATIONS (Past and Present)

 

American Society of Retina Specialists

American Academy of Ophthalmology

Association for Research in Vision and Ophthalmology

Alpha Omega Alpha Honor Medical Society

American Society for Gene Therapy

Tau Beta Pi (Engineering)

American Medical Student Association

Texas Medical Student Association

Texas Society of Pathologists

Baylor Pediatrics Student Association - Research Coordinator

 

 

PATENTS

 

Metabolic Biotinylation of Proteins in Mammalian Cells

Inventor: Michael A. Barry, Ph.D. and M. Brandon Parrott, M.D.,Ph.D.

Technology Status: This technology has been used successfully in the inventor's laboratory to express biotinylated cellular and viral proteins in cultured mammalian cells and in living mammals.

 

Patent Status: US Patent application filed.

Availability: Available for exclusive or non-exclusive license for therapeutic applications and non-exclusive for other applications.

Project Manager: Terese Rakow, Office of Technology Administration, Baylor College of Medicine

 

 

MEDICAL LICENSES AND CERTIFICATIONS

 

State of Florida – Department of Health

Medical Doctor – Active

ME #102018 – Issued 2008

 

State of North Carolina – NC Medical Board

Medical Doctor – Active

Certificate #217718 – Issued 2016  

 

State of Tennessee – Division of Health Related Boards

Medical Doctor – Inactive

MD 45763 – Issued December 2009

 

American Board of Ophthalmology – Board Certified

 

United States Medical Licensing Examination (USMLE) - #5-025-890-4

Step I (Pass / 99 / 258)

Step II (Pass / 99 / 260)

Step III (Pass / 98 / 237)